Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc. announced today the Government of Quebec will continue to provide public funding of JARDIANCE® (empagliflozin), SYNJARDY® (a single-pill combination of empagliflozin and metformin), and TRAJENTA
Boehringer Ingelheim (Canada) Ltd. and Eli Lilly Canada Inc. announced today the Government of Quebec will continue to provide public funding of JARDIANCE® (empagliflozin), SYNJARDY® (a single-pill combination of empagliflozin and metformin), and TRAJENTA